Digestive Diseases and Sciences

, Volume 33, Issue 3, pp 263–269 | Cite as

Hepatitis B vaccination

Response of alcoholic with and without liver injury
  • Charles Mendenhall
  • Gary A. Roselle
  • Lisa A. Lybecker
  • Laine E. Marshall
  • Charles J. Grossman
  • Steven A. Myre
  • Robert E. Weesner
  • David D. Morgan
Original Articles

Abstract

Alcoholics are at risk to develop hepatitis B infections, chronic active hepatitis, and even hepatoma. Hence, immunization with hepatitis B vaccine is recommended. However, immune abnormalities may coexist which alter their responsiveness to vaccination. This study compares the immune response to this vaccine in controls (group I), alcoholics without overt liver disease (group II), and alcoholics with clinical liver disease (group III). By the seventh month after the initial vaccination, 89% in group I, 70% in group II, and 18% in group III had a response >36 RIA units. The magnitude of the response was significantly different in groups I, II, and III (19,456 vs 8,326 vs 153 RIA units, respectively; P <0.05, group I vs III). In those who did not respond, a significant (P < 0.02) lower helper/inducer (T4)class of lymphocytes was observed as compared to patients who exhibited an adequate response. These observations suggest: (1) that the response to hepatitis B vaccine is a T-cell-dependent event and (2) that in this population, using the existing vaccine, postvaccination evaluations of antibody concentrations are needed before protection against hepatitis B infection can be assumed.

Key words

alcoholics hepatitis B vaccine anti-HBs helper T-lymphocytes 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Galambos JT: Alcoholic hepatitis.In The Liver and Its Diseases. F Schaffner, S Sherlock, CM Leevy (eds). New York, Intercontinental Medical Book, 1974, pp 255–267Google Scholar
  2. 2.
    Stone WD, Islam NRK, Paton A: The natural history of cirrhosis. Q J Med 37:119–132, 1974Google Scholar
  3. 3.
    Pettigrew NM, Goudie RB, Russell RI, Chaudhuri AKR: Evidence for a role of hepatitis virus B in chronic alcoholic liver disease. Lancet 2:724–725, 1972PubMedGoogle Scholar
  4. 4.
    Brechot C, Nalpas B, Courouce AM, Degos F, Duhamel G, Tiollais P, Berthelot P: Detection of hepatitis B virus (HBV) DNA in liver of patients with alcoholic liver disease. Hepatology 1:499, 1981Google Scholar
  5. 5.
    Stigendal L, Hermodsson S, Olsson R: Prevalence of markers of hepatotrophic viruses in alcoholics with symptomatic liver cirrhosis or pancreatitis. Scand J Gastroenterol 19:588–590, 1984PubMedGoogle Scholar
  6. 6.
    Buffet C, Attali P, Papoz L, Chaput JC, Etienne JP: Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Dig Dis Sci 27:473–474, 1982Google Scholar
  7. 7.
    Martines D, Chiaramonte M, Lazzari F De, Floreani A, Cibin M, Pornaro E, Naccarato R: The role of hepatitis B virus in the pathogenesis of chronic hepatitis in alcoholics. Hepatology 2:181, 1982.Google Scholar
  8. 8.
    Gluud C, Aldershvill J, Henriksen J, Kryger P, Mathiesen L: Hepatitis B and A virus antibodies in alcoholic steatosis and cirrhosis. J Clin Pathol 35:693–697, 1982PubMedGoogle Scholar
  9. 9.
    Mills PR, Follett EAC, Urquhart GED, Clements G, Watkinson G, MacSween RNM: Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Br Med J 282:437–438, 1981Google Scholar
  10. 10.
    Hislop WS, Follett EAC, Bouchier IAD, MacSween RNM: Serologic markers of hepatitis B in patients with alcoholic liver disease: A multicenter survey. J Clin Pathol 34:1017–1019, 1981PubMedGoogle Scholar
  11. 11.
    Mendenhall CL, the VA Cooperative Study Group on Alcoholic Hepatitis: Alcoholic hepatitis. Clin Gastroenterol 10:417–441, 1981PubMedGoogle Scholar
  12. 12.
    Bjorkholm M: Immunological and hematological abnormalities in chronic alcoholism. Acta Med Scand 207:197–200, 1980PubMedGoogle Scholar
  13. 13.
    Lundy J, Raaf JH, Deakins S, Wanebo HJ, Jacobs DA, Lee T, Jacobowitz D, Spear C, Oettgen HF: The acute and chronic effects of alcohol on the human immune system. Surg Gynecol Obstet 141:212–219, 1975PubMedGoogle Scholar
  14. 14.
    Smith FE, Palmer DL: Alcoholism, infection and altered host defenses: a review of clinical and experimental observations. J Chron Dis 29:35–49, 1976PubMedGoogle Scholar
  15. 15.
    Kanagasundaram N, Leevy CM: Ethanol, immune reactions and the digestive system. Clin Gastroenterol 10:295–306, 1981PubMedGoogle Scholar
  16. 16.
    Smith WI Jr, Van Thiel DH, Whiteside T, Janoson B, Magovern J, Puet T, Rabin BS: Altered immunity in male patients with alcoholic liver disease: Evidence for defective immune regulation. Alc Clin Exp Res 4:199–206, 1980Google Scholar
  17. 17.
    Bernstein IM, Webster KH, Williams RC Jr, Strickland RD: Reduction in circulating T lymphocytes in alcoholic liver disease. Lancet 2:488–490, 1974PubMedGoogle Scholar
  18. 18.
    Berenyi MR, Straus B, Avila L: T rosettes in alcoholic cirrhosis of the liver. JAMA 232:44–46, 1975PubMedGoogle Scholar
  19. 19.
    Havens WP, Shaffer JM, Hopke CJ: The production of antibody by patients with chronic hepatic disease. J Immunol 67:347–356, 1951PubMedGoogle Scholar
  20. 20.
    Pirovino M, Lydick E, Grob PJ, Arrenbrecht S, Altorfer J, Schmid M: Pneumococcal vaccination: The response of patients with alcoholic liver cirrhosis. Hepatology 4:946–949, 1984PubMedGoogle Scholar
  21. 21.
    Abbott Laboratories Diagnostic Division: Hepatitis B Surface Antigen I (Human) (Subtypes ad and ay) AUSAB. Package Insert. September 1983, p 14Google Scholar
  22. 22.
    Blackburn GL, Bistrain BR, Maini BS, Schlamm HT, Smith MF: Nutritional and metabolic assessment of the hospitalized patient. J Parent Enter Nutr 1:11–22, 1977Google Scholar
  23. 23.
    Mendenhall C, Bongiovanni G, Goldberg S, Miller B, Moore J, Rouster S, Schneider S, Tamburro C. Tosch T, Weesner R, the VA Cooperative Study Group on Alcoholic Hepatitis: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enterai nutrition therapy. J Parent Enter Nutr 9:590–596, 1985Google Scholar
  24. 24.
    Haravovi B, Wilder R, Malone D, Allen J, Katona I, Wahl S: Immune function in severe, active rheumatoid arthritis: A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles. J Immunol 133:697–701, 1984PubMedGoogle Scholar
  25. 25.
    Roselle G, Mendenhall C: Alterations ofin vitro human lymphocyte function by ethanol, acetaldehyde, and acetate. J Clin Lab Immunol 9:33–37, 1982PubMedGoogle Scholar
  26. 26.
    Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A: Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 303:833–841, 1980PubMedGoogle Scholar
  27. 27.
    Francis DP, Hadler SC, Thompson SE, Maynard JE, Ostrow DG, Altman N, Braff EH, O'Malley P, Hawkins D, Judson FN, Penley K, Nylund T, Christie G, Meyers F, Moore JN, Gardner A, Doto IL, Miller JH, Reynolds GH, Murphy BL, Schable CA, Clark BT, Curran JW, Redeker AG: The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control multicenter efficacy trial among homosexual men. Ann Intern Med 97:362–366, 1982PubMedGoogle Scholar
  28. 28.
    Dienstag JL, Werner BG, Polk F, Snydman DR, Craven DE, Platt R, Crumpacker CS, Ouellet-Hellstrom R, Grady GF: Hepatitis B vaccine in health care personnel: Safety, immunogenicity, and indicators of efficacy. Ann Intern Med 101:34–40, 1984PubMedGoogle Scholar
  29. 29.
    Huff BB (ed): Physicians Desk Reference, 38th ed. Heptavax-B (hepatitis B vaccine). Oradell, New Jersey, Medical Economics Co., 1984, p 1285Google Scholar
  30. 30.
    Mendenhall C, Anderson S, Weesner RE, Goldberg SJ, Crolic KA: Protein-calorie malnutrition associated with alcoholic hepatitis. Am J Med 76:211–222, 1984PubMedGoogle Scholar
  31. 31.
    Roselle G, Mendenhall CL: Immune alterations in alcoholic hepatitis: effects of enterai nutrition therapy. Hepatology 4:1031, 1984Google Scholar
  32. 32.
    Degos F, Brechot C, Nalpas B, Duhamel G, Courouce AM, Tron F, Berthelot P: Hepatitis B vaccination and alcoholic cirrhosis. Lancet 2:1498, 1983Google Scholar
  33. 33.
    Gilliland BC: Introduction to clinical immunology.In: Harrison's Principles of Internal Medicine, 10th ed. Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD (eds). New York, McGraw-Hill, 1983, p 344–391Google Scholar
  34. 34.
    Cupps TR, Gerin JL, Purcell RH, Goldsmith PK, Fauci AS:In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. J Clin Invest 74:1204–1213, 1984PubMedGoogle Scholar
  35. 35.
    Nowicki MJ, Tong MJ, Bohman RE: Alterations in the immune response of nonresponders to the hepatitis B vaccine. J Infect Dis 152:1245–1248, 1985PubMedGoogle Scholar
  36. 36.
    Mendenhall CL, Roselle GA, Grossman CJ, Rouster SD, Weesner RE: False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis. N Engl J Med 314:921–922, 1986 (letter)PubMedGoogle Scholar
  37. 37.
    Gross RL, Newherne PM: Role of nutrition in immunologic function. Physiol Rev 60:188–302, 1980PubMedGoogle Scholar
  38. 38.
    Stevens CE, Szumness W, Goodman AI, Weseley SA, Fotino M: Hepatitis B vaccine: Immune responses in hemodialysis patients. Lancet 2:1211–1213, 1980PubMedGoogle Scholar
  39. 39.
    Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W, the Dialysis Vaccine Trial Study Group: Hepatitis B vaccine in patients receiving hemodialysis. N Engl J Med311:496–501, 1984PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • Charles Mendenhall
    • 1
    • 2
    • 3
    • 4
  • Gary A. Roselle
    • 1
    • 2
    • 3
    • 4
  • Lisa A. Lybecker
    • 1
    • 2
    • 3
    • 4
  • Laine E. Marshall
    • 1
    • 2
    • 3
    • 4
  • Charles J. Grossman
    • 1
    • 2
    • 3
    • 4
  • Steven A. Myre
    • 1
    • 2
    • 3
    • 4
  • Robert E. Weesner
    • 1
    • 2
    • 3
    • 4
  • David D. Morgan
    • 1
    • 2
    • 3
    • 4
  1. 1.VA Medical CenterHepatic Research LaboratoryCincinnati
  2. 2.Department of MedicineThe College of PharmacyUSA
  3. 3.Department of Physiology and BiophysicsUniversity of Cincinnati Medical CenterCincinnati
  4. 4.Department of Biological SciencesXavier UniversityCincinnati

Personalised recommendations